Veterinary Biomarkers Market Size

Veterinary Biomarkers Market Size

Veterinary Biomarkers Market size was valued at USD 798.5 million in 2023 and is estimated to grow at 9.9% CAGR from 2024 to 2032. The market has seen considerable growth due to the increasing awareness and emphasis on early disease diagnosis and monitoring for animal healthcare.

To get key market trends

  Download Free Sample

For instance, according to the American Veterinary Medical Association in April 2022, purebred dogs have a 1.9 times higher relative risk of cancer compared to non-purebred dogs. In veterinary oncology, biomarkers are essential for diagnosis, prognosis, staging, and monitoring of therapeutic outcomes. These factors are expected to increase the adoption of veterinary biomarkers, thereby contributing to the market's growth. Additionally, the growing pet population and the trend of pet humanization are leading to increased spending on animal health.
 

Furthermore, the veterinary field is witnessing an upsurge in research activities and pharmaceutical developments aimed at improving animal health, thereby propelling the demand for veterinary biomarkers and contributing to market expansion. In addition, growing technological advancements in biomarker testing, such as rapid and point-of-care diagnostics, contribute to market growth.
 

Veterinary biomarkers are measurable indicators of normal biological processes, disease states, or responses to treatments in animals. They can include molecules, cells, genes, or other biological characteristics that are objectively measured to assess animal health, diagnose diseases, and monitor therapeutic outcomes. These biomarkers are essential in veterinary medicine for early disease detection, prognosis, drug development, and personalized treatment plans.